This company listing is no longer active
Osstem Implant Past Earnings Performance
Past criteria checks 5/6
Osstem Implant has been growing earnings at an average annual rate of 43.7%, while the Medical Equipment industry saw earnings growing at 24.5% annually. Revenues have been growing at an average rate of 20.3% per year. Osstem Implant's return on equity is 38.2%, and it has net margins of 15%.
Key information
43.7%
Earnings growth rate
43.9%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 20.3% |
Return on equity | 38.2% |
Net Margin | 15.0% |
Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
When Should You Buy Osstem Implant Co., Ltd. (KOSDAQ:048260)?
Apr 12Introducing Osstem Implant (KOSDAQ:048260), The Stock That Zoomed 182% In The Last Year
Mar 11Here's Why We Don't Think Osstem Implant's (KOSDAQ:048260) Statutory Earnings Reflect Its Underlying Earnings Potential
Feb 15Do Institutions Own Osstem Implant Co., Ltd. (KOSDAQ:048260) Shares?
Jan 25Is Osstem Implant Co., Ltd.'s (KOSDAQ:048260) 45% ROE Better Than Average?
Dec 14Osstem Implant Co., Ltd.'s (KOSDAQ:048260) Intrinsic Value Is Potentially 97% Above Its Share Price
Nov 23Revenue & Expenses BreakdownBeta
How Osstem Implant makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 23 | 1,105,209 | 165,681 | 401,786 | 39,331 |
31 Dec 22 | 1,053,472 | 138,137 | 389,095 | 38,936 |
30 Sep 22 | 1,017,445 | 51,092 | 467,207 | 38,310 |
30 Jun 22 | 951,138 | 41,834 | 447,219 | 36,725 |
31 Mar 22 | 887,193 | 39,539 | 421,311 | 35,849 |
31 Dec 21 | 824,566 | 25,012 | 402,829 | 33,414 |
30 Sep 21 | 781,007 | 116,932 | 282,887 | 29,681 |
30 Jun 21 | 732,739 | 154,466 | 266,376 | 26,055 |
31 Mar 21 | 672,451 | 126,796 | 251,304 | 23,335 |
31 Dec 20 | 631,596 | 107,046 | 245,210 | 21,424 |
30 Sep 20 | 584,206 | 68,561 | 243,632 | 20,459 |
30 Jun 20 | 567,035 | -35,420 | 240,587 | 19,585 |
31 Mar 20 | 566,716 | -30,919 | 240,877 | 19,642 |
31 Dec 19 | 565,043 | -16,262 | 235,339 | 19,586 |
30 Sep 19 | 542,621 | -15,752 | 228,021 | 19,121 |
30 Jun 19 | 508,848 | 18,592 | 212,992 | 18,487 |
31 Mar 19 | 480,670 | 18,441 | 206,588 | 17,650 |
31 Dec 18 | 460,147 | 12,691 | 202,060 | 16,189 |
30 Sep 18 | 438,878 | 5,540 | 200,946 | 15,236 |
30 Jun 18 | 424,438 | 11,731 | 202,327 | 14,400 |
31 Mar 18 | 412,751 | 15,433 | 195,710 | 13,511 |
31 Dec 17 | 397,791 | 10,107 | 191,408 | 12,628 |
30 Sep 17 | 396,964 | 22,002 | 185,197 | 11,776 |
30 Jun 17 | 384,905 | 19,605 | 175,445 | 10,717 |
31 Mar 17 | 360,315 | 15,329 | 166,636 | 9,373 |
31 Dec 16 | 344,582 | 23,500 | 154,372 | 8,380 |
30 Sep 16 | 317,715 | 13,169 | 138,305 | 7,466 |
30 Jun 16 | 301,127 | 16,423 | 129,669 | 6,497 |
31 Mar 16 | 294,615 | 20,199 | 124,772 | 5,914 |
31 Dec 15 | 277,703 | 17,949 | 118,731 | 5,193 |
30 Sep 15 | 266,607 | 24,630 | 111,696 | 4,354 |
30 Jun 15 | 251,726 | 21,183 | 107,714 | 4,110 |
31 Mar 15 | 241,584 | 15,203 | 103,320 | 3,491 |
31 Dec 14 | 235,933 | 15,003 | 102,305 | 3,084 |
30 Sep 14 | 231,473 | 13,404 | 105,221 | 2,860 |
30 Jun 14 | 229,359 | 10,949 | 104,528 | 2,569 |
31 Mar 14 | 226,227 | 12,228 | 106,416 | 2,491 |
31 Dec 13 | 215,665 | 9,803 | 105,134 | 2,507 |
30 Sep 13 | 208,776 | 5,723 | 102,359 | 2,479 |
30 Jun 13 | 203,490 | 4,754 | 100,774 | 1,909 |
31 Mar 13 | 198,724 | 5,559 | 95,689 | 2,819 |
31 Dec 12 | 198,894 | 4,916 | 93,749 | 2,717 |
Quality Earnings: A048260 has a high level of non-cash earnings.
Growing Profit Margin: A048260's current net profit margins (15%) are higher than last year (4.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A048260's earnings have grown significantly by 43.7% per year over the past 5 years.
Accelerating Growth: A048260's earnings growth over the past year (319%) exceeds its 5-year average (43.7% per year).
Earnings vs Industry: A048260 earnings growth over the past year (319%) exceeded the Medical Equipment industry 19.9%.
Return on Equity
High ROE: A048260's Return on Equity (38.2%) is considered high.